Graser CJ, McDonald TO, Catalano PJ, Sonpavde G, Michor F.2025.Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab.Journal for immunotherapy of cancer.13(5).Pubmed: 40341029DOI:10.1136/jitc-2025-011740
Graser CJ, McDonald TO, Catalano PJ, Sonpavde G, Michor F.2025.Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab.Journal for immunotherapy of cancer.13(5).Pubmed: 40341029DOI:10.1136/jitc-2025-011740
Franziska Michor uses the tools of theoretical evolutionary biology, applied mathematics, statistics, and computational biology to address important questions in cancer research.
